Maybe, but it doesn't have to be that way IMO. There's plenty of potential for recurring revenue streams too in defence, oil and gas, infrastructure etc. Still plenty to play out.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025